Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|October 3, 2011

Diagnostic Imaging Editorial Advisory Board

Abass Alavi, MD

Professor in Radiology Department

Hospital of the University of Pennsylvania

Philadelphia, PA

William G. Bradley Jr, MD, PhD, FACR

Professor and Chairman, Department of Radiology

UCSD Medical Center

San Diego, CA 

Garry Choy, MD

Staff Radiologist

Massachusetts General Hospital, Division of Emergency Radiology and Teleradiology

Boston, MA

Stamatia Destounis, MD

Managing Partner and Radiologist, Elizabeth Wende Breast Care

Rochester, NY

Allen Elster, MD, FACR

Radiology Professor at Wake Forest Baptist Medical Center

Winston-Salem, NC

Elliot K. Fishman, MD

Professor, Radiology and Oncology

Director, Diagnostic Imaging and Body CT

The Johns Hopkins Hospital

Baltimore, MD

David Hirschorn, MD

Director of Radiology Informatics, Staten Island University Hospital

Researcher in Radiology Informatics, Massachusetts General Hospital

Alan Kaye, MD, FACR

President, Advanced Radiology Consultants

Radiology Department Chair, Bridgeport Hospital

Bridgeport, CT

Mark Klein, MD

Radiologist, Washington Radiology Associates

Washington, DC

Robert Pyatt, MD

CEO, Chambersburg Imaging Associates, PC

Chairman, Cumberland Valley Health Network

Chambersburg, PA

Bruce Reiner, MD

Director of Radiology Research at the VA Maryland Health Care System, Baltimore

Radiologist, Virtual Radiologic (vRad)

Ronald B. Schilling

President, RBS Consulting Group

Los Altos, CA

Eliot L. Siegel, MD

Professor of Diagnostic Radiology and Nuclear Medicine

Director, Baltimore Veterans Affairs Medical Center Radiology

Associate Vice Chairman for Informatics

University of Maryland Medical Center

Baltimore, MD

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.